secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2024-11-27T23:59:59+00:00
Accession:  0001213900-24-103498
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Actinium re-elects Class II directors Seth and Chell, ratifies Marcum as auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Sandesh Seth and Jeffrey W. Chell re-elected as Class II directors for three-year terms expiring at 2027 annual meeting.
- Marcum LLP ratified as independent registered public accounting firm for fiscal year ending Dec 31, 2024.
- Approximately 63.2% of outstanding shares (19.7M of 31.2M) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390024103498/0001213900-24-103498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390024103498/ea0222950-8k_actinium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-103498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer